Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Intangibles (2016 - 2025)

Historic Intangibles for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to $60.3 million.

  • Harvard Bioscience's Intangibles rose 195.77% to $60.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.3 million, marking a year-over-year increase of 195.77%. This contributed to the annual value of $58.5 million for FY2024, which is 35.12% down from last year.
  • Latest data reveals that Harvard Bioscience reported Intangibles of $60.3 million as of Q3 2025, which was up 195.77% from $60.1 million recorded in Q2 2025.
  • Over the past 5 years, Harvard Bioscience's Intangibles peaked at $65.7 million during Q2 2021, and registered a low of $58.3 million during Q1 2024.
  • For the 5-year period, Harvard Bioscience's Intangibles averaged around $61.5 million, with its median value being $61.1 million (2023).
  • Its Intangibles has fluctuated over the past 5 years, first crashed by 569.56% in 2022, then skyrocketed by 292.44% in 2025.
  • Over the past 5 years, Harvard Bioscience's Intangibles (Quarter) stood at $64.9 million in 2021, then decreased by 5.7% to $61.2 million in 2022, then decreased by 4.15% to $58.7 million in 2023, then decreased by 0.35% to $58.5 million in 2024, then increased by 3.09% to $60.3 million in 2025.
  • Its last three reported values are $60.3 million in Q3 2025, $60.1 million for Q2 2025, and $59.1 million during Q1 2025.